Dr. Xiaojin An is a European patent attorney and has been working at the Jones Day Munich office since 2013. She also holds Chinese patent attorney qualification. Her practice focuses on obtaining and defending intellectual property rights for clients in the fields of pharmaceuticals, biotechnology, and diagnostics. She has extensive experience in antibodies, peptides, vaccines, stem cells, immune therapies, diagnostic methods, gene editing, and personalized medicine.

Xiaojin represents clients in patent proceedings before the European Patent Office, including drafting, prosecution, opposition, and appeal. She also has experience in national invalidity and infringement proceedings. Xiaojin advises clients on opposing and defending patents, freedom-to-operate, patent life cycle management, and supplementary protection certificates (SPCs). In addition to managing global patent portfolios, Xiaojin conducts IP due diligence in connection with merger, acquisition, and license agreements.

Prior to joining Jones Day, Xiaojin was a postdoctoral fellow at the Swiss Federal Institute of Technology Zurich (ETH). Xiaojin carried out her Ph.D. studies at Harvard Medical School and Peking University.